Results 11 to 20 of about 51,036 (282)
Secondary coenzyme Q 10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders [PDF]
We evaluated the coenzyme Q₁₀ (CoQ) levels in patients who were diagnosed with mitochondrial oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders (n=72). Data from the 72 cases in this study revealed that 44.4% of patients showed low CoQ concentrations in either their skeletal muscle or skin fibroblasts.
Yubero, D. +53 more
core +7 more sources
OXPHOS mutations and neurodegeneration [PDF]
Mitochondrial oxidative phosphorylation (OXPHOS) sustains organelle function and plays a central role in cellular energy metabolism. The OXPHOS system consists of 5 multisubunit complexes (CI-CV) that are built up of 92 different structural proteins encoded by the nuclear (nDNA) and mitochondrial DNA (mtDNA).
Koopman, W.J.H. +3 more
openaire +6 more sources
Bayesian classification of OXPHOS deficient skeletal myofibres [PDF]
Mitochondria are organelles in most human cells which release the energy required for cells to function. Oxidative phosphorylation (OXPHOS) is a key biochemical process within mitochondria required for energy production and requires a range of proteins and protein complexes.
Jordan Childs +4 more
core +11 more sources
Mitochondrial disorders of the OXPHOS system [PDF]
Mitochondrial disorders are among the most frequent inborn errors of metabolism, their primary cause being the dysfunction of the oxidative phosphorylation system (OXPHOS). OXPHOS is composed of the electron transport chain (ETC), formed by four multimeric enzymes and two mobile electron carriers, plus an ATP synthase [also called complex V (cV)].
Fernandez-Vizarra, Erika +1 more
openaire +5 more sources
OXPHOS toxicogenomics and Parkinson's disease
Activities and quantities of several oxidative phosphorylation (OXPHOS) system complexes are decreased in many Parkinson's disease (PD) patients. Mutations in PD-associated nuclear genes affect OXPHOS function. Moreover, the inactivation of other nuclear genes related to mitochondrial DNA (mtDNA) replication and expression also leads to Parkinsonism ...
López-Gallardo,E. +4 more
openaire +4 more sources
Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases [PDF]
Mitochondria participate in essential processes in the nervous system such as energy and intermediate metabolism, calcium homeostasis, and apoptosis. Major neurodegenerative diseases are characterized pathologically by accumulation of misfolded proteins as a result of gene mutations or abnormal protein homeostasis.
Hibiki Kawamata, Giovanni Manfredi
openaire +3 more sources
Mitoribosomal regulation of OXPHOS biogenesis in plants [PDF]
The ribosome filter hypothesis posits that ribosomes are not simple non-selective translation machines but may also function as regulatory elements in protein synthesis. Recent data supporting ribosomal filtering come from plant mitochondria where it has been shown that translation of mitochondrial transcripts encoding components of oxidative ...
Janska, Hanna, Kwasniak, Malgorzata
openaire +5 more sources
Crif1 deficiency reduces adipose OXPHOS capacity and triggers inflammation and insulin resistance in mice. [PDF]
Impaired mitochondrial oxidative phosphorylation (OXPHOS) has been proposed as an etiological mechanism underlying insulin resistance. However, the initiating organ of OXPHOS dysfunction during the development of systemic insulin resistance has yet to be
Min Jeong Ryu +20 more
doaj +4 more sources
The molecular evolutionary dynamics of oxidative phosphorylation (OXPHOS) genes in Hymenoptera [PDF]
Background The primary energy-producing pathway in eukaryotic cells, the oxidative phosphorylation (OXPHOS) system, comprises proteins encoded by both mitochondrial and nuclear genes.
Yiyuan Li +9 more
doaj +2 more sources
OXPHOS-targeting drugs in oncology: new perspectives
Drugs targeting mitochondria are emerging as promising antitumor therapeutics in preclinical models. However, a few of these drugs have shown clinical toxicity. Developing mitochondria-targeted modified natural compounds and US FDA-approved drugs with increased therapeutic index in cancer is discussed as an alternative strategy.Triphenylphosphonium ...
Kalyanaraman, Balaraman +3 more
openaire +4 more sources

